Investigation to identify a resource-efficient case-control methodology for determining antibiotics associated with Clostridium difficile infection

Philip Chung, Brian Currie, Yi Guo, Moshe Talansky, Shakara Brown, Belinda Ostrowsky

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background Antimicrobial exposure remains an important risk factor for developing Clostridium difficile infection (CDI). Efficient method to identify antibiotics associated with CDI is important for formulating strategies to curtail their use. As a prelude to a more extensive Agency for Healthcare Research and Quality-funded project (Evaluation & Research on Antimicrobial Stewardship's Effect on Clostridium difficile), we undertook an exploratory evaluation to determine a resource-efficient method for identifying antibiotic targets for antimicrobial stewardship interventions. Methods The study compared a series of 6 focused case-control studies. Cases consisted of patients with laboratory-confirmed CDI admitted from July-October 2009. Controls were selected from patients without CDI hospitalized during the same period. Five groups of controls were matched to cases (2:1 ratio) using group-specific matching criteria, including admission date, age, type of admission, length of stay (LOS) to discharge, and/or LOS to CDI diagnosis. The final control group was selected from patients who received antibiotics during hospitalization. Data, including demographics and antibiotic usage, were compared between case and control groups. Results A total of 126 cases were matched to 6 groups of 252 controls. For control groups 1-5, the use of piperacillin and tazobactam, ceftriaxone or cefepime, ciprofloxacin or moxifloxacin, intravenous vancomycin, azithromycin, and antibiotics of last resort were significantly more frequent in case than control patients. For the final control group, the associations between ceftriaxone or cefepime, and ciprofloxacin or moxifloxacin use and CDI no longer persisted. This could in part be explained by differences in comorbidities between case and control patients even with stringent matching criteria. Conclusion Use of a simple matching strategy to conduct case-control studies is an efficient and feasible compromise strategy, especially in resource-limited settings, to identify high-risk antibiotics associated with CDI.

Original languageEnglish (US)
Pages (from-to)S264-S268
JournalAmerican Journal of Infection Control
Volume42
Issue number10
DOIs
StatePublished - Oct 1 2014

Fingerprint

Clostridium Infections
Clostridium difficile
Anti-Bacterial Agents
Control Groups
Ceftriaxone
Ciprofloxacin
Case-Control Studies
Length of Stay
Azithromycin
Health Services Research
Vancomycin
Comorbidity
Hospitalization
Demography

Keywords

  • Antibiotic targets
  • Antimicrobial stewardship
  • Case control
  • Clostridium difficile

ASJC Scopus subject areas

  • Epidemiology
  • Medicine(all)
  • Health Policy
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Investigation to identify a resource-efficient case-control methodology for determining antibiotics associated with Clostridium difficile infection. / Chung, Philip; Currie, Brian; Guo, Yi; Talansky, Moshe; Brown, Shakara; Ostrowsky, Belinda.

In: American Journal of Infection Control, Vol. 42, No. 10, 01.10.2014, p. S264-S268.

Research output: Contribution to journalArticle

Chung, Philip ; Currie, Brian ; Guo, Yi ; Talansky, Moshe ; Brown, Shakara ; Ostrowsky, Belinda. / Investigation to identify a resource-efficient case-control methodology for determining antibiotics associated with Clostridium difficile infection. In: American Journal of Infection Control. 2014 ; Vol. 42, No. 10. pp. S264-S268.
@article{f4b7e35391e344b8a8072a26eb32ed1d,
title = "Investigation to identify a resource-efficient case-control methodology for determining antibiotics associated with Clostridium difficile infection",
abstract = "Background Antimicrobial exposure remains an important risk factor for developing Clostridium difficile infection (CDI). Efficient method to identify antibiotics associated with CDI is important for formulating strategies to curtail their use. As a prelude to a more extensive Agency for Healthcare Research and Quality-funded project (Evaluation & Research on Antimicrobial Stewardship's Effect on Clostridium difficile), we undertook an exploratory evaluation to determine a resource-efficient method for identifying antibiotic targets for antimicrobial stewardship interventions. Methods The study compared a series of 6 focused case-control studies. Cases consisted of patients with laboratory-confirmed CDI admitted from July-October 2009. Controls were selected from patients without CDI hospitalized during the same period. Five groups of controls were matched to cases (2:1 ratio) using group-specific matching criteria, including admission date, age, type of admission, length of stay (LOS) to discharge, and/or LOS to CDI diagnosis. The final control group was selected from patients who received antibiotics during hospitalization. Data, including demographics and antibiotic usage, were compared between case and control groups. Results A total of 126 cases were matched to 6 groups of 252 controls. For control groups 1-5, the use of piperacillin and tazobactam, ceftriaxone or cefepime, ciprofloxacin or moxifloxacin, intravenous vancomycin, azithromycin, and antibiotics of last resort were significantly more frequent in case than control patients. For the final control group, the associations between ceftriaxone or cefepime, and ciprofloxacin or moxifloxacin use and CDI no longer persisted. This could in part be explained by differences in comorbidities between case and control patients even with stringent matching criteria. Conclusion Use of a simple matching strategy to conduct case-control studies is an efficient and feasible compromise strategy, especially in resource-limited settings, to identify high-risk antibiotics associated with CDI.",
keywords = "Antibiotic targets, Antimicrobial stewardship, Case control, Clostridium difficile",
author = "Philip Chung and Brian Currie and Yi Guo and Moshe Talansky and Shakara Brown and Belinda Ostrowsky",
year = "2014",
month = "10",
day = "1",
doi = "10.1016/j.ajic.2014.05.001",
language = "English (US)",
volume = "42",
pages = "S264--S268",
journal = "American Journal of Infection Control",
issn = "0196-6553",
publisher = "Mosby Inc.",
number = "10",

}

TY - JOUR

T1 - Investigation to identify a resource-efficient case-control methodology for determining antibiotics associated with Clostridium difficile infection

AU - Chung, Philip

AU - Currie, Brian

AU - Guo, Yi

AU - Talansky, Moshe

AU - Brown, Shakara

AU - Ostrowsky, Belinda

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Background Antimicrobial exposure remains an important risk factor for developing Clostridium difficile infection (CDI). Efficient method to identify antibiotics associated with CDI is important for formulating strategies to curtail their use. As a prelude to a more extensive Agency for Healthcare Research and Quality-funded project (Evaluation & Research on Antimicrobial Stewardship's Effect on Clostridium difficile), we undertook an exploratory evaluation to determine a resource-efficient method for identifying antibiotic targets for antimicrobial stewardship interventions. Methods The study compared a series of 6 focused case-control studies. Cases consisted of patients with laboratory-confirmed CDI admitted from July-October 2009. Controls were selected from patients without CDI hospitalized during the same period. Five groups of controls were matched to cases (2:1 ratio) using group-specific matching criteria, including admission date, age, type of admission, length of stay (LOS) to discharge, and/or LOS to CDI diagnosis. The final control group was selected from patients who received antibiotics during hospitalization. Data, including demographics and antibiotic usage, were compared between case and control groups. Results A total of 126 cases were matched to 6 groups of 252 controls. For control groups 1-5, the use of piperacillin and tazobactam, ceftriaxone or cefepime, ciprofloxacin or moxifloxacin, intravenous vancomycin, azithromycin, and antibiotics of last resort were significantly more frequent in case than control patients. For the final control group, the associations between ceftriaxone or cefepime, and ciprofloxacin or moxifloxacin use and CDI no longer persisted. This could in part be explained by differences in comorbidities between case and control patients even with stringent matching criteria. Conclusion Use of a simple matching strategy to conduct case-control studies is an efficient and feasible compromise strategy, especially in resource-limited settings, to identify high-risk antibiotics associated with CDI.

AB - Background Antimicrobial exposure remains an important risk factor for developing Clostridium difficile infection (CDI). Efficient method to identify antibiotics associated with CDI is important for formulating strategies to curtail their use. As a prelude to a more extensive Agency for Healthcare Research and Quality-funded project (Evaluation & Research on Antimicrobial Stewardship's Effect on Clostridium difficile), we undertook an exploratory evaluation to determine a resource-efficient method for identifying antibiotic targets for antimicrobial stewardship interventions. Methods The study compared a series of 6 focused case-control studies. Cases consisted of patients with laboratory-confirmed CDI admitted from July-October 2009. Controls were selected from patients without CDI hospitalized during the same period. Five groups of controls were matched to cases (2:1 ratio) using group-specific matching criteria, including admission date, age, type of admission, length of stay (LOS) to discharge, and/or LOS to CDI diagnosis. The final control group was selected from patients who received antibiotics during hospitalization. Data, including demographics and antibiotic usage, were compared between case and control groups. Results A total of 126 cases were matched to 6 groups of 252 controls. For control groups 1-5, the use of piperacillin and tazobactam, ceftriaxone or cefepime, ciprofloxacin or moxifloxacin, intravenous vancomycin, azithromycin, and antibiotics of last resort were significantly more frequent in case than control patients. For the final control group, the associations between ceftriaxone or cefepime, and ciprofloxacin or moxifloxacin use and CDI no longer persisted. This could in part be explained by differences in comorbidities between case and control patients even with stringent matching criteria. Conclusion Use of a simple matching strategy to conduct case-control studies is an efficient and feasible compromise strategy, especially in resource-limited settings, to identify high-risk antibiotics associated with CDI.

KW - Antibiotic targets

KW - Antimicrobial stewardship

KW - Case control

KW - Clostridium difficile

UR - http://www.scopus.com/inward/record.url?scp=84922121151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922121151&partnerID=8YFLogxK

U2 - 10.1016/j.ajic.2014.05.001

DO - 10.1016/j.ajic.2014.05.001

M3 - Article

C2 - 25239720

AN - SCOPUS:84922121151

VL - 42

SP - S264-S268

JO - American Journal of Infection Control

JF - American Journal of Infection Control

SN - 0196-6553

IS - 10

ER -